| Tag | Content |
|---|
EnhancerAtlas ID | HS145-11713 |
Organism | Homo sapiens |
Tissue/cell | NHBE |
Coordinate | chr19:36193040-36193820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59463 | chr19:36184851-36210443 | Ly3 | | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | AGGCGTGAGC CACCACGTCC GGCCCCTTCC CCCATTTTAG CGGTTTCGCT CCCTATCGGG 60
GCCAGGGACG CCTCAGGCTG TCTCGGTCAG GACCTACAGC TCCGGTTGTT GTCCCAGGCT 120
CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC CACCCCCATT CCTCCCCACT CCAGCTCCTC 180
AGCGAGCGGC TGCGAAGGAC GCGCACAACA ACACTCCGCG CAGCGGGAAG GTACCGAACT 240
CGCATCGCAG CCTGAAACTG CTCAACTAAG CTCCCGCCCC GCTGCTCTCT GGTCAATCTA 300
AAGCGAAGAC GAGCCTTAGG GCCAATCAGA AGCGACAGCG GTGGAGTCAT GCCCGCCTGC 360
TTGAGGCGCC CTGGCGTCTC ATTGGCTATG CTTGAGAACG AATCCCAGGC TAAGCCACTT 420
AGAAAGGAGC GGAGCCAGCC AATCAGCGGT GCAACCGCCG CGGGGGCCGG GCCAGAAGCC 480
CCGCAGACAA GCACCTCGGG AGACTGGCGA GGGGCGAGCT CGCAGCTTGT TAGCCCCGAA 540
GCCCTGCCCA GGGGGAAACC CTGCTGGAGG GAGTCTAACC CCCGGGCCAG TTAATGTTGG 600
GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT ATGGTTGGAG GTGGGAGTGC TGACACGTCC 660
GCGCGCAGTT ACTCCTGGCT GAGCATACAG TCGAGGTGGC AGTGGGAATT GGAAGTGCAA 720
GTGTCACGCT GCCAATCACG GGGCAAGGCA CTGCCCCCCT CTTGTGTCTT TCCTGTCCCT 780
|
